Proapoptotic activated T-cells in the blood of children with Down's syndrome: Relationship with dietary antigens and intestinal alterations

International Journal of Tissue Reactions

Volumn 25, Issue 3, 2003, Pages 117-125

  Corsi, M M ^a   Ponti, W ^a   Venditti, A ^a   Ferrara, F ^a   Baldo, C ^b   Chiappelli, M ^c   Licastro, F ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD3 ANTIGEN; FAS ANTIGEN; GLIADIN; GLIADIN ANTIBODY; HLA DR ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 6; LIPOCORTIN 5; PROPIDIUM IODIDE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; APOPTOSIS; ARTICLE; CELIAC DISEASE; CELL ACTIVATION; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXIC T LYMPHOCYTE; DIET; DISEASE ASSOCIATION; DOWN SYNDROME; ENTEROPATHY; FEMALE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INCIDENCE; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE; MAJOR CLINICAL STUDY; MALE; NUTRIENT LOADING; PHENOTYPE; PROTEIN BLOOD LEVEL; SCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ANNEXIN A5; ANTIGENS; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD95; APOPTOSIS; CELIAC DISEASE; CELLS, CULTURED; COLORING AGENTS; DOWN SYNDROME; FEMALE; GLIADIN; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INCIDENCE; INTERLEUKIN-6; INTESTINAL DISEASES; LYMPHOCYTE ACTIVATION; MALE; PROPIDIUM; T-LYMPHOCYTES;

EID: 0347316391     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lejeune J., Gautier M., Turpin R. Les chromosomes humains en culture de tissus. C.R. Acad. Sci., 248, 602, 1959.
2. Baird P.A., Sadovnick A.D. Causes of death to age 30 in Down syndrome. Am. J. Hum. Gen., 43, 239, 1988.
3. Murdoch J.C., Ratcliffe W.A., McLarty D.G., Rodger J.C., Ratcliffe J.G. Thyroid function in adults with Down's syndrome. J. Clin. Endocr. Metab., 44, 453, 1977.
4. Licastro F., Chiricolo M., Tabacchi P.L., Barboni F., Zannotti M., Franceschi C. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects. Cell. Immunol., 75, 111, 1983.
5. Fabris N., Mocchegiani E., Amadio L., Zanotti M., Licastro F., Franceschi C. Thymic hormone deficiency in normal aging and Down's syndrome: Is there a primary failure of the thymus? Lancet, 1, 983, 1984.
6. Longdon Down J.H. Observations on an ethnic on an ethnic classification of idiots. Clin. Lect. Reps., 3, 59, 1866.
7. Franceschi C., Licastro F., Chiricolo M., et al. Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome. J. Immunol., 126, 2161, 1981.
8. Licastro F., Melotti C., Parente R., et al. Derangement of non-specific immunity in Down syndrome subjects. Low leukocyte chemiluminescence activity after phagocytic activation. Am. J. Med. Genet., 7, 242, 1990.
9. Licastro F., Chiricolo M., Mocchegiani E., et al. Oral zinc supplementation in Down's syndrome subjects decreases infections and normalized some humoral and cellular immune parameters. J. Intell. Disability Res., 38, 149, 1994.
10. Franceschi C., Chiricolo M., Licastro F., et al. Oral zinc supplementation in Down's syndrome: Restoration of thymic endocrine activity and of some immune defects. J. Ment. Defic. Res., 32, 169, 1988.
11. Carlsson A., Axelsson J., Borulf S., et al. Prevalence of IgA-antigliadin antibodies and IgA-anti endomysium antibodies related to coeliac disease in children with Down syndrome. Pediatrics, 101, 272, 1998.
12. Gale L., Wilamaratna H., Brotodiharjo A., Duggan J.M. Down's syndrome is strongly associated with coeliac disease. Gut, 40, 492, 1997.
13. Lazzari R., Collina A., Arena G., et al. Coeliac disease in children with Down syndrome. Ped. Med. Chir., 16, 467, 1994.
14. Licastro F., Mocchegiani E., Zanotti M., Arena G., Masi M., Fabris N. Zinc affects the metabolism of thyroid hormones in children with Down's syndrome: Normalization of thyroid stimulating hormone and of reversal triiodo thyronine plasmic levels by dietary zinc supplementation. Intern. J. Neurosci., 65, 259, 1992.
15. Licastro F., Chiricolo M., Moccheggiani E., et al. Impairment of T cell subpopulations and thymic endocrine function in children with Down's syndrome: A possible pathogenetic role of zinc. J. Immunological Res., 2, 95, 1990.
16. Taylor C.G., Giesbecht J.A. Dietary zinc deficiency and expression of T lymphocyte signal transduction proteins. Can. J. Physiol. Pharmacol., 78, 823, 2000.
17. Truong-Tran A.Q., Ho L.H., Chai F., Zalewski P.D. Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. J. Nutr. 13, 1459S, 2000.
18. Trubiani O., Antonucci A., Palka G.D., Di Primio R. Programmed cell death of peripheral myeloid precursor cells in Down patients: Effect of zinc therapy. Ultrastruc. Pathol., 20, 457, 1996.
19. Antonucci A., Di Baldassarre A., Di Giacomo F., Stuppia L., Palka G.D. Detection of apoptosis in peripheral blood cells of 31 subjects affected by Down syndrome before and after zinc therapy. Ultrastruc. Pathol., 21, 449, 1997.
20. Krammer P.H. The CD95 (APO-1/Fas)/CD95L system. Toxicol. Lett., 102, 131, 1998.
21. Blakenberg F.G., Katsikis P.D., Tait J.F., et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci. USA, 26, 6349, 1998.
22. Yasui K., Shinozaki K., Nakazawa T., Agematsu K., Komiyama A. Presenility of granulocytes in Down syndrome individuals. Am. J. Med. Genet., 84, 406, 1999.
23. Seidl R., Fang-Kircher S., Bidmon B., Cairns N., Lubec G. Apoptosis-associated protein p53 and APO-I/Fas (Cd95) in brains of adult patients with Down's syndrome. Neurosci. Lett., 260, 9, 1999.
24. Cifone M.G., De Maria R., Roncaioli P., et al. Apoptotic signalling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med., 180, 1547, 1994.
25. Licastro F., Pedrini S., Caputo L., et al. Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: Peripheral inflammation or signal from the brain? J. Neuroimmunol., 103, 97, 2000.
26. Holland A.J., Hon J., Huppert F.A., Stevens F. Incidence of dementia in people with Down's syndrome: Findings from a population-based study. J. Intellect. Disability Res., 44, 138, 2000.
27. Kumar V., Rajadhyaksha M., Wortsman J. Celiac disease-associated autoimmune endocrinopaties. Clin. Diagn. Lab. Immun., 8, 678, 2001.
28. Tilg H., Dinarello C.A., Mier J.M. IL-6 and Apps: Anti-inflammatory and immunosuppressive mediators. Immunol. Today, 18, 428, 1997.
29. Williams C.A., Quinn H., Wright E.C., Sylvester P.E., Gosling P.J., Dickerson J.W. Xylose absorption in Down's syndrome. J. Ment. Defic. Res., 29, 173, 1985.
30. Chimienti F., Seve M., Richard S., Mathieu J., Favier A. Role of cellular zinc in programmed cell death: Temporal relationship between zinc depletion, activation of caspase and cleavage of Sp family transcription factors. Biochem. Pharmacol., 62, 51, 2001.
31. Chai F., Truong-Trag A.Q., Evdokiou A., Young G.P., Zalewski P.D. Intracellular zinc depletion induces caspase activation and p21/CipI cleavage in human epithelial cell line. J. Infect. Dis., 182, 85, 2000.
32. Fraker P.J., King L.E., Laako T., Vollmer T.L. The dynamic link between the integrity of the immune system and zinc status. J. Nutr., 130, 1399, 2000.
33. Schindowski K., Leutner S., Muller W.E., Eckert A. Age-accelerated changes of apoptotic death in human lymphocytes. Neurobiol. Aging, 21, 661, 2000.
34. Lechner H., Amort M., Steger M.M., Maczek C., Grubek-Loebstein B. Regulation of CD95 (APO-1) expression and the induction of apoptosis in human T cells: Changes in old age. Int. Arch. Allergy Immunol., 110, 238, 1996.
35. Bambrick L.L., Krueger B.K. Neuronal apoptosis in mouse trisomy 16: Mediation by caspases. J. Neurochem., 72, 1769, 1999.